Stay updated on Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page.

Latest updates to the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.5.0 was added to the Record History page, updating the version shown. The prior revision v3.4.3 is removed from the history listing.SummaryDifference0.1%

- Check26 days agoChange DetectedThe history adds Active, not recruiting status and updates to Contacts/Locations, Study Design, Study Status, and Recruitment Status, along with a new revision entry (v3.4.3) dated 2026-03-06; the prior Recruiting status was removed (2025-10-09, v3.4.2).SummaryDifference0.7%

- Check54 days agoChange DetectedA new revision entry, Revision: v3.4.2, was added. The notice about government funding lapse (Revision: v3.4.1) was removed.SummaryDifference0.6%

- Check61 days agoChange DetectedA new funding notice was added and the page revision was updated to v3.4.1 (replacing v3.4.0); these are administrative updates that do not affect study details.SummaryDifference0.6%

- Check68 days agoChange DetectedUI changes to the history page include color-coded diffs (green additions, red deletions with strikethroughs), a glossary toggle, and an updated revision label (v3.4.0) plus a No FEAR Act Data label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check82 days agoChange DetectedThe revision history now shows a new version v3.3.4 and removes v3.3.3, reflecting routine version control for the page, and it does not affect the study content or current record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page.